Kara M Kelly

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate
    Jennifer M Levine
    Herbert Irving Child and Adolescent Oncology Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Pediatr Hematol Oncol 28:711-4. 2006
  2. doi Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma
    Kara M Kelly
    Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Columbia University Medical Center, New York, NY 10032, USA
    Pediatr Blood Cancer 60:972-8. 2013
  3. doi Management of children with high-risk Hodgkin lymphoma
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, NY 10032, USA
    Br J Haematol 157:3-13. 2012
  4. ncbi Bringing evidence to complementary and alternative medicine in children with cancer: Focus on nutrition-related therapies
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, New York, USA
    Pediatr Blood Cancer 50:490-3; discussion 498. 2008
  5. pmc BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, NY 10032, USA
    Blood 117:2596-603. 2011
  6. ncbi Complementary and alternative medicines for use in supportive care in pediatric cancer
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, Morgan Stanley Children s Hospital of New York Presbyterian, New York, NY 10032, USA
    Support Care Cancer 15:457-60. 2007
  7. ncbi Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704
    K M Kelly
    College of Physicians and Surgeons of Columbia University, Children s Hospital of New York, NY 10032, USA
    Ann Oncol 13:107-11. 2002
  8. doi Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, Morgan Stanley Children s Hospital of New York Presbyterian, New York, New York 10032, USA
    Pediatr Blood Cancer 52:33-8. 2009
  9. ncbi Complementary and alternative medical therapies for children with cancer
    Kara M Kelly
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, IP 7, New York, NY 10032, USA
    Eur J Cancer 40:2041-6. 2004
  10. ncbi Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications
    K M Kelly
    College of Physicians and Surgeons of Columbia University, Children s Hospital of New York, NY 10032, USA
    Ann Oncol 13:34-9. 2002

Collaborators

Detail Information

Publications31

  1. ncbi Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate
    Jennifer M Levine
    Herbert Irving Child and Adolescent Oncology Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Pediatr Hematol Oncol 28:711-4. 2006
    ..The frequency of false positive (FP) PET scans in pediatric HD after completion of therapy has not been well studied...
  2. doi Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma
    Kara M Kelly
    Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Columbia University Medical Center, New York, NY 10032, USA
    Pediatr Blood Cancer 60:972-8. 2013
    ..A phase 3 trial will modify conventional chemotherapy and radiotherapy approaches through the addition of Bv, while incorporating translational biology to identify molecular targets...
  3. doi Management of children with high-risk Hodgkin lymphoma
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, NY 10032, USA
    Br J Haematol 157:3-13. 2012
    ..New directions in prognostic classification and targeted therapies are reviewed. Considerations for clinical practice at the current time outside the clinical trial setting are provided...
  4. ncbi Bringing evidence to complementary and alternative medicine in children with cancer: Focus on nutrition-related therapies
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, New York, USA
    Pediatr Blood Cancer 50:490-3; discussion 498. 2008
    ..Strong research designs are critical in obtaining information that will ultimately influence clinical practice and public awareness...
  5. pmc BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, New York, NY 10032, USA
    Blood 117:2596-603. 2011
    ..This trial is registered at http://www.clinicaltrials.gov as #NCT00004010...
  6. ncbi Complementary and alternative medicines for use in supportive care in pediatric cancer
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, Morgan Stanley Children s Hospital of New York Presbyterian, New York, NY 10032, USA
    Support Care Cancer 15:457-60. 2007
    ..Complementary and alternative medical practices (CAM) are being used by increasing numbers of children with cancer...
  7. ncbi Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704
    K M Kelly
    College of Physicians and Surgeons of Columbia University, Children s Hospital of New York, NY 10032, USA
    Ann Oncol 13:107-11. 2002
    ....
  8. doi Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy
    Kara M Kelly
    Division of Pediatric Oncology, Columbia University Medical Center, Morgan Stanley Children s Hospital of New York Presbyterian, New York, New York 10032, USA
    Pediatr Blood Cancer 52:33-8. 2009
    ....
  9. ncbi Complementary and alternative medical therapies for children with cancer
    Kara M Kelly
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, IP 7, New York, NY 10032, USA
    Eur J Cancer 40:2041-6. 2004
    ..Research is needed before biologically based CAM therapies may be recommended in conjunction with conventional therapy...
  10. ncbi Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications
    K M Kelly
    College of Physicians and Surgeons of Columbia University, Children s Hospital of New York, NY 10032, USA
    Ann Oncol 13:34-9. 2002
    ..These investigations may ultimately allow the use of pharmacogenetically guided therapy to improve the outcome of HL therapy and reduce the risk of therapy-related complications, especially secondary malignancies...
  11. ncbi Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment
    Deborah D Kennedy
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Pediatr Blood Cancer 44:378-85. 2005
    ..Children undergoing treatment for acute lymphoblastic leukemia (ALL) receive combination chemotherapy and many of the components are associated with free radical production...
  12. doi Use of complementary and alternative medicine among children, adolescent, and young adult cancer survivors: a survey study
    Deborah H Ndao
    Division of Pediatric Oncology Blood and Marrow Transplantation, Columbia University Medical Center, New York, NY 10032, USA
    J Pediatr Hematol Oncol 35:281-8. 2013
    ..The main objective of this study was to investigate the prevalence of complementary and alternative medicine (CAM) use, types and reasons for use, and determinants of use among survivors of childhood cancer...
  13. pmc Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, SM 17, New York, NY 10065, USA
    J Clin Oncol 30:3174-80. 2012
    ..We present the long-term study outcome using final data through March 2007...
  14. pmc A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
    Elena J Ladas
    Division of Pediatric Oncology, Columbia University Medical Center, New York, New York 10032, USA
    Cancer 116:506-13. 2010
    ..Limited treatment options exist for chemotherapy-related hepatoxicity. Given the wide use of MT, the authors investigated MT in both the laboratory and a clinical setting...
  15. ncbi 8-oxo-dG elevated in children during leukemia treatment
    Deborah D Kennedy
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Integr Cancer Ther 3:301-9. 2004
    ..04). In conclusion, the level of 8-oxo-dG in blood mononuclear cells decreases after the start of chemotherapy and increases during aggressive chemotherapy in children with ALL...
  16. doi Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial
    Deborah H Ndao
    Division of Pediatric Oncology, Columbia University Medical Center, New York, NY 10032, USA
    Psychooncology 21:247-54. 2012
    ..Though often lifesaving, stem cell transplantation (SCT) is a period of great distress for both child and parent...
  17. ncbi Antioxidants and cancer therapy: a systematic review
    Elena J Ladas
    Division of Pediatric Oncology, Children s Hospital of New York, New York, NY, USA
    J Clin Oncol 22:517-28. 2004
    ....
  18. ncbi Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer?
    Elena J Ladas
    Division of Pediatric Oncology, Columbia University, New York, NY, USA
    J Altern Complement Med 9:411-6. 2003
    ..Currently, there are no safer alternatives to these medications. Milk thistle (Silybum marianum) is a botanical that may be useful in the prevention or treatment of liver dysfunction in patients undergoing anticancer therapy...
  19. doi The safety of acupuncture in children and adolescents with cancer therapy-related thrombocytopenia
    Elena J Ladas
    Division of Pediatric Oncology, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA
    Support Care Cancer 18:1487-90. 2010
    ..However, the safety of acupuncture in patients with cancer treatment-related thrombocytopenia has not been previously investigated...
  20. ncbi Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia
    Deborah D Kennedy
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Clin Nutr 79:1029-36. 2004
    ....
  21. ncbi Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma
    Maria Luisa Sulis
    Division of Pediatric Oncology, Children s Hospital of New York, Columbia University, 161 Fort Washington Avenue, Irving Pavilion 7, New York, NY 10032, USA
    J Pediatr Hematol Oncol 26:843-6. 2004
    ..The dose and schedule of administration of actinomycin D in patients with Wilms tumor and the increased dose of cyclophosphamide administered to patients with rhabdomyosarcoma have been considered the likely etiology for VOD...
  22. doi Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in Guatemala
    Elena J Ladas
    Division of Pediatric Hematology, Oncology, Stem Cell Transplant, Columbia University, New York, New York
    Pediatr Blood Cancer 61:687-92. 2014
    ..As part of a regional initiative, we present the results of the first survey exploring use of TCAM among children with cancer residing in Latin America...
  23. doi Adult orbital langerhans cell histiocytosis with frontal bone involvement
    Jason A Sokol
    Department of Ophthalmology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA
    Ophthal Plast Reconstr Surg 25:157-8. 2009
    ..The systemic workup was negative for multifocal lesions and for diabetes insipidus. In addition to subtotal resection, the patient was treated with a 6-month course of oral prednisone and intravenous vinblastine...
  24. doi Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science
    Jessica Hochberg
    Department of Pediatrics, Columbia University, New York, NY 10032, USA
    Br J Haematol 144:24-40. 2009
    ....
  25. ncbi Advances in the use of milk thistle (Silybum marianum)
    Janice Post-White
    University of Minnesota, Minneapolis, Minnesota 55403, USA
    Integr Cancer Ther 6:104-9. 2007
    ..More clinical trials of rigorous methodology, using standardized and well-defined products and dosages, are needed to evaluate the potential of silymarin against liver toxicity, chronic liver disease, and human cancers...
  26. ncbi Complementary and alternative therapies in pediatric oncology
    Susan F Sencer
    Department of Pediatric Oncology, Children s Hospitals and Clinics of Minnesota, 2525 Chicago Avenue S, Minneapolis, MN 55404, USA
    Pediatr Clin North Am 54:1043-60; xiii. 2007
    ....
  27. doi Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Brian D Lawenda
    Radiation Oncology Division, Breast Health Center, Naval Medical Center San Diego, San Diego, CA, USA
    J Natl Cancer Inst 100:773-83. 2008
    ....
  28. ncbi Bringing evidence to complementary and alternative medicine for children with cancer
    Susan F Sencer
    Division of Hematology Oncology, Children s Hospitals and Clinics of Minnesota, Minneapolis, MN, USA
    J Pediatr Hematol Oncol 28:186-9. 2006
  29. ncbi Integrative Tumor Board: pediatric synovial sarcoma
    Linda Granowetter
    Integr Cancer Ther 5:48-55. 2006
  30. ncbi Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology Group
    Donna L Johnston
    Division of Hematology Oncology, Children s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
    Pediatr Blood Cancer 47:955-8. 2006
    ..Despite published widespread use of CAM therapies, our study demonstrates that institutional CAM resources and policies on CAM are present in much lower proportions...
  31. ncbi Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate
    Jennifer M Levine
    J Pediatr Hematol Oncol 29:667. 2007